Abstract
Glutathione S-transferase P1 (GSTP1) is one of the important mutant sites for the cancer risk at present. The conclusions of the published reports on the relationship between GSTP1 A/G gene polymorphism and the risk of breast cancer are still debated. This meta-analysis was performed to evaluate the association between GSTP1 and the risk of breast cancer. The association reports were identified from PubMed and Cochrane Library, and eligible studies were included and synthesized using meta-analysis method. 35 investigations were included into this meta-analysis for the association of GSTP1 A/G gene polymorphism and breast cancer susceptibility, consisting of 40,347 subjects (18,665 patients with breast cancer and 21,682 controls). The association between GSTP1 A/G gene polymorphism and breast cancer risk was not found for overall population, Caucasians and Africans. Interestingly, the GSTP1 A/G gene polymorphism was associated with the susceptibility of breast cancer in Asians (G allele: OR = 1.10, 95 % CI: 1.04–1.17, P = 0.001; GG genotype: OR = 1.36, 95 % CI: 1.14–1.62, P = 0.0008; AA genotype: OR = 0.92, 95 % CI: 0.85–0.98, P = 0.02). Furthermore, the GSTP1 A/G gene polymorphism was associated with the susceptibility of breast cancer for the analysis of the controls from hospital. In conclusion, GSTP1 A/G gene polymorphism is associated with the breast cancer susceptibility in Asians. However, more studies on the relationship between GSTP1 A/G gene polymorphism and the risk of breast cancer should be performed in further.
Similar content being viewed by others
References
Tian W, Chen J, He H, Deng Y (2012) MicroRNAs and drug resistance of breast cancer: basic evidence and clinical applications. Clin Transl Oncol. doi:10.1007/s12094-012-0929-5
Ibrahim NI, Dahlui M, Aina E, Al-Sadat N (2012) Who are the breast cancer survivors in Malaysia? Asian Pac J Cancer Prev 13:2213–2218
Wang L, Wang G, Lu C, Feng B, Kang J (2012) Contribution of the -160C/A polymorphism in the E-cadherin promoter to cancer risk: a meta-analysis of 47 case-control Studies. PLoS One 7:40219
Xu JL, Yin ZQ, Huang MD, Wang XF, Gao W, Liu LX et al (2012) MLH1 polymorphisms and cancer risk: a meta-analysis based on 33 case-control studies. Asian Pac J Cancer Prev 13:901–907
Gao M, Wang Y, Shi Y, Liu D, Liang Y, Yu Y et al (2012) The relationship between three well-characterized polymorphisms of the angiotensin converting enzyme gene and lung cancer risk: a case-control study and a meta-analysis. J Renin Angiotensin Aldosterone Syst. doi:10.1177/1470320312443912
Zhou TB, Liu YG, Lin N, Qin YH, Huang K, Shao MB et al (2012) Relationship between angiotensin-converting enzyme insertion/deletion gene polymorphism and systemic lupus erythematosus/lupus nephritis: a systematic review and metaanalysis. J Rheumatol 39:686–693
Zhou TB, Ou C, Qin YH, Su LN, Lei FY, Huang WF et al (2011) Association of angiotensin converting enzyme insertion/deletion gene polymorphism with idiopathic nephrotic syndrome susceptibility in children: a meta-analysis. J Renin Angiotensin Aldosterone Syst 12:601–610
Wang H, Zhou Y, Zhuang W, Yin YQ, Liu GJ, Wu TX et al (2010) Glutathione S-transferase M1 null genotype associated with gastric cancer among Asians. Dig Dis Sci 55:1824–1830
Tew KD, Townsend DM (2012) Glutathione-S-transferases as determinants of cell survival and death. Antioxid Redox Signal. doi:10.1089/ars.2012.4640
Board PG, Webb GC, Coggan M (1989) Isolation of a cDNA clone and localization of the human glutathione S-transferase 3 genes to chromosome bands 11q13 and 12q13-14. Ann Hum Genet 53:205–213
Ramalhinho AC, Fonseca-Moutinho JA, Breitenfeld L (2011) Glutathione S-transferase M1, T1, and P1 genotypes and breast cancer risk: a study in a Portuguese population. Mol Cell Biochem 355:265–271
Ruzzo A, Canestrari E, Maltese P, Pizzagalli F, Graziano F, Santini D et al (2007) Polymorphisms in genes involved in DNA repair and metabolism of xenobiotics in individual susceptibility to sporadic diffuse gastric cancer. Clin Chem Lab Med 45:822–828
Zhang LF, Mi YY, Qin C, Wang Y, Cao Q, Wei JF et al (2011) RNASEL -1385G/A polymorphism and cancer risk: a meta-analysis based on 21 case-control studies. Mol Biol Rep 38:5099–5105
Zhou TB, Qin YH, Ou C, Su LN, Lei FY, Huang WF et al (2012) A meta-analysis of the association between angiotensin-converting enzyme insertion/deletion gene polymorphism and steroid-sensitive nephrotic syndrome in children. J Renin Angiotensin Aldosterone Syst 13:175–183
Zhou TB, Qin YH, Su LN, Lei FY, Huang WF, Zhao YJ et al (2011) The association between angiotensin-converting enzyme insertion/deletion gene variant and risk of focal segmental glomerulosclerosis: a systematic review and meta-analysis. J Renin Angiotensin Aldosterone Syst 12:624–633
Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101
Egger M, Davey SG, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634
Harries LW, Stubbins MJ, Forman D, Howard GC, Wolf CR (1997) Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 18:641–644
Helzlsouer KJ, Selmin O, Huang HY, Strickland PT, Hoffman S, Alberg AJ et al (1998) Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. J Natl Cancer Inst 90:512–518
Curran JE, Weinstein SR, Griffiths LR (2000) Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer susceptibility. Cancer Lett 153:113–120
Millikan R, Pittman G, Tse CK, Savitz DA, Newman B, Bell D (2000) Glutathione S-transferases M1, T1, and P1 and breast cancer. Cancer Epidemiol Biomarkers Prev 9:567–573
Maugard CM, Charrier J, Pitard A, Campion L, Akande O, Pleasants L et al (2001) Genetic polymorphism at the glutathione S-transferase (GST) P1 locus is a breast cancer risk modifier. Int J Cancer 91:334–339
Krajinovic M, Ghadirian P, Richer C, Sinnett H, Gandini S, Perret C et al (2001) Genetic susceptibility to breast cancer in French–Canadians: role of carcinogen-metabolizing enzymes and gene-environment interactions. Int J Cancer 92:220–225
Zhao M, Lewis R, Gustafson DR, Wen WQ, Cerhan JR, Zheng W (2001) No apparent association of GSTP1 A(313)G polymorphism with breast cancer risk among postmenopausal Iowa women. Cancer Epidemiol Biomarkers Prev 10:1301–1302
Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma VM, Benhamou S et al (2001) Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer. Cancer Epidemiol Biomarkers Prev 10:229–236
Gudmundsdottir K, Tryggvadottir L, Eyfjord JE (2001) GSTM1, GSTT1, and GSTP1 genotypes in relation to breast cancer risk and frequency of mutations in the p53 gene. Cancer Epidemiol Biomarkers Prev 10:1169–1173
Kim SU, Lee KM, Park SK, Yoo KY, Noh DY, Choe KJ et al (2004) Genetic polymorphism of glutathione S-transferase P1 and breast cancer risk. J Biochem Mol Biol 37:582–585
Egan KM, Cai Q, Shu XO, Jin F, Zhu TL, Dai Q et al (2004) Genetic polymorphisms in GSTM1, GSTP1, and GSTT1 and the risk for breast cancer: results from the Shanghai breast cancer study and meta-analysis. Cancer Epidemiol Biomarkers Prev 13:197–204
Sarmanova J, Susova S, Gut I, Mrhalova M, Kodet R, Adamek J et al (2004) Breast cancer: role of polymorphisms in biotransformation enzymes. Eur J Hum Genet 12:848–854
Ceschi M, Sun CL, Van Den Berg D, Koh WP, Yu MC, Probst-Hensch N (2005) The effect of cyclin D1 (CCND1) G870A-polymorphism on breast cancer risk is modified by oxidative stress among Chinese women in Singapore. Carcinogenesis 26:1457–1464
Chang TW, Wang SM, Guo YL, Tsai PC, Huang CJ, Huang W (2006) Glutathione S-transferase polymorphisms associated with risk of breast cancer in southern Taiwan. Breast 15:754–761
Nordgard SH, Ritchie MD, Jensrud SD, Motsinger AA, Alnaes GI, Lemmon G et al (2007) ABCB1 and GST polymorphisms associated with TP53 status in breast cancer. Pharmacogenet Genomics 17:127–136
Edvardsen H, Kristensen VN, Grenaker AG, Bohn M, Erikstein B, Helland A et al (2007) Germline glutathione S-transferase variants in breast cancer: relation to diagnosis and cutaneous long-term adverse effects after two fractionation patterns of radiotherapy. Int J Radiat Oncol Biol Phys 67:1163–1171
Spurdle AB, Chang JH, Byrnes GB, Chen X, Dite GS, McCredie MR et al (2007) A systematic approach to analysing gene–gene interactions: polymorphisms at the microsomal epoxide hydrolase EPHX and glutathione S-transferase GSTM1, GSTT1, and GSTP1 loci and breast cancer risk. Cancer Epidemiol Biomarkers Prev 16:769–774
Steck SE, Gaudet MM, Britton JA, Teitelbaum SL, Terry MB, Neugut AI et al (2007) Interactions among GSTM1, GSTT1 and GSTP1 polymorphisms, cruciferous vegetable intake and breast cancer risk. Carcinogenesis 28:1954–1959
Syamala VS, Sreeja L, Syamala V, Raveendran PB, Balakrishnan R, Kuttan R et al (2008) Influence of germline polymorphisms of GSTT1, GSTM1, and GSTP1 in familial versus sporadic breast cancer susceptibility and survival. Fam Cancer 7:213–220
Rajkumar T, Samson M, Rama R, Sridevi V, Mahji U, Swaminathan R et al (2008) TGFbeta1 (Leu10Pro), p53 (Arg72Pro) can predict for increased risk for breast cancer in south Indian women and TGFbeta1 Pro (Leu10Pro) allele predicts response to neo-adjuvant chemo-radiotherapy. Breast Cancer Res Treat 112:81–87
Unlu A, Ates NA, Tamer L, Ates C (2008) Relation of glutathione S-transferase T1, M1 and P1 genotypes and breast cancer risk. Cell Biochem Funct 26:643–647
Torresan C, Oliveira MM, Torrezan GT, de Oliveira SF, Abuazar CS, Losi-Guembarovski R et al (2008) Genetic polymorphisms in oestrogen metabolic pathway and breast cancer: a positive association with combined CYP/GST genotypes. Clin Exp Med 8:65–71
Lee SA, Fowke JH, Lu W, Ye C, Zheng Y, Cai Q et al (2008) Cruciferous vegetables, the GSTP1 Ile105Val genetic polymorphism, and breast cancer risk. Am J Clin Nutr 87:753–760
Sakoda LC, Blackston CR, Xue K, Doherty JA, Ray RM, Lin MG et al (2008) Glutathione S-transferase M1 and P1 polymorphisms and risk of breast cancer and fibrocystic breast conditions in Chinese women. Breast Cancer Res Treat 109:143–155
Van Emburgh BO, Hu JJ, Levine EA, Mosley LJ, Perrier ND, Freimanis RI et al (2008) Polymorphisms in CYP1B1, GSTM1, GSTT1 and GSTP1, and susceptibility to breast cancer. Oncol Rep 19:1311–1321
Kadouri L, Kote-Jarai Z, Hubert A, Baras M, Abeliovich D, Hamburger T et al (2008) Glutathione-S-transferase M1, T1 and P1 polymorphisms, and breast cancer risk, in BRCA1/2 mutation carriers. Br J Cancer 98:2006–2010
Antognelli C, Del BC, Ludovini V, Gori S, Talesa VN, Crino L et al (2009) CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control study. BMC Cancer 9:115
Saxena A, Dhillon VS, Raish M, Asim M, Rehman S, Shukla NK et al (2009) Detection and relevance of germline genetic polymorphisms in glutathione S-transferases (GSTs) in breast cancer patients from northern Indian population. Breast Cancer Res Treat 115:537–543
Reding KW, Weiss NS, Chen C, Li CI, Carlson CS, Wilkerson HW et al (2009) Genetic polymorphisms in the catechol estrogen metabolism pathway and breast cancer risk. Cancer Epidemiol Biomarkers Prev 18:1461–1467
McCarty KM, Santella RM, Steck SE, Cleveland RJ, Ahn J, Ambrosone CB et al (2009) PAH-DNA adducts, cigarette smoking, GST polymorphisms, and breast cancer risk. Environ Health Perspect 117:552–558
Pongtheerat T, Treetrisool M, Purisa W (2009) Glutathione s-transferase polymorphisms in breast cancers of Thai patients. Asian Pac J Cancer Prev 10:127–132
MARIE-GENICA (2010) Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women. Breast Cancer Res Treat 119:463–474
Kaushal M, Mishra AK, Raju BS, Ihsan R, Chakraborty A, Sharma J et al (2010) Betel quid chewing as an environmental risk factor for breast cancer. Mutat Res 703:143–148
Cerne JZ, Novakovic S, Frkovic-Grazio S, Pohar-Perme M, Stegel V, Gersak K (2011) Estrogen metabolism genotypes, use of long-term hormone replacement therapy and risk of postmenopausal breast cancer. Oncol Rep 26:479–485
Gong M, Dong W, An R (2012) Glutathione S-transferase T1 polymorphism contributes to bladder cancer risk: a meta-analysis involving 50 Studies. DNA Cell Biol 31(7):1187–1197
Kadivar M, Maf N, Joulaee A, Shamshiri A, Hosseini N (2012) Breast cancer molecular subtypes and associations with clinicopathological characteristics in Iranian women, 2002–2011. Asian Pac J Cancer Prev 13:1881–1886
Sergentanis TN, Economopoulos KP (2010) GSTT1 and GSTP1 polymorphisms and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 121:195–202
Lu S, Wang Z, Cui D, Liu H, Hao X (2011) Glutathione S-transferase P1 Ile105Val polymorphism and breast cancer risk: a meta-analysis involving 34,658 subjects. Breast Cancer Res Treat 125:253–259
Yao L, Ji G, Gu A, Zhao P, Liu N (2012) An updated pooled analysis of glutathione S-transferase genotype polymorphisms and risk of adult gliomas. Asian Pac J Cancer Prev 13:157–163
Bin Q, Luo J (2012) The Role of polymorphisms of the GSTM1, GSTT1 and GSTP1 Ile105Val in Hodgkin’s and Non-Hodgkin’s Lymphoma Risk: A HUGE Review. Leuk Lymphoma
Zhao ZQ, Guan QK, Yang FY, Zhao P, Zhou B, Chen ZJ (2012) System review and metaanalysis of the relationships between five metabolic gene polymorphisms and colorectal adenoma risk. Tumour Biol 33:523–535
Funding
None.
Conflict of interest
The authors declare no competing interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, JJ., Liu, JL., Zhang, X. et al. A meta-analysis of the association of glutathione S-transferase P1 gene polymorphism with the susceptibility of breast cancer. Mol Biol Rep 40, 3203–3212 (2013). https://doi.org/10.1007/s11033-012-2396-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-012-2396-z